APO-ACEBUTOLOL TABLET
Land: Canada
Taal: Engels
Bron: Health Canada
Productkenmerken
(SPC)
24-10-2018
Sommige documenten voor dit product zijn momenteel niet beschikbaar, u kunt een verzoek sturen naar onze klantenservice en we zullen u hiervan op de hoogte stellen zodra we ze kunnen verkrijgen.
Verzend verzoek.
Verzend verzoek.
Werkstoffen:
ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE)
Beschikbaar vanaf:
APOTEX INC
ATC-code:
C07AB04
INN (Algemene Internationale Benaming):
ACEBUTOLOL
Dosering:
100MG
farmaceutische vorm:
TABLET
Samenstelling:
ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) 100MG
Toedieningsweg:
ORAL
Eenheden in pakket:
100 & 500 TABLETS
Prescription-type:
Prescription
Therapeutisch gebied:
BETA-ADRENERGIC BLOCKING AGENTS
Product samenvatting:
Active ingredient group (AIG) number: 0131282001; AHFS:
Autorisatie-status:
MARKETED
Autorisatie datum:
1995-12-31
Productkenmerken
_APO-ACEBUTOLOL Product Monograph _
_ _
_ _
_ _
_Page 1 of 34 _
_ _
PRODUCT MONOGRAPH
PR APO-ACEBUTOLOL
ACEBUTOLOL TABLETS (AS ACEBUTOLOL HYDROCHLORIDE)
APOTEX STANDARD
100 MG, 200 MG AND 400 MG TABLETS
ANTIHYPERTENSIVE AND ANTI-ANGINAL AGENT
APOTEX INC.
DATE OF REVISION:
150 SIGNET DRIVE
OCTOBER 24, 2018
TORONTO, ONTARIO
M9L 1T9
CONTROL NUMBER# 220342
_APO-ACEBUTOLOL Product Monograph _
_ _
_ _
_ _
_Page 2 of 34 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..................................................................................................
3
SUMMARY PRODUCT INFORMATION
...................................................................................................................
3
INDICATIONS AND CLINICAL USE
.........................................................................................................................
3
CONTRAINDICATIONS
..............................................................................................................................................
4
WARNINGS AND PRECAUTIONS
............................................................................................................................
4
ADVERSE REACTIONS
..............................................................................................................................................
9
DRUG INTERACTIONS
.............................................................................................................................................
11
DOSAGE AND ADMINISTRATION
.........................................................................................................................
15
OVERDOSAGE
...........................................................................................................................................................
16
ACTION AND CLINICAL PHARMACOLOGY
.......................................................................................................
17
STORAGE AND STABILITY
...........................................
Lees het volledige document
